Contact
info@topadur.com+41 44 755 44 66Topadur Pharma AG
Grabenstrasse 11A
8952 Schlieren, Switzerland
Grabenstrasse 11A
8952 Schlieren, Switzerland
Read the full interview:
TOPADUR announces positive results from an interim analysis of Phase I clinical trial with their new wound healing drug candidate.
Read moreTOPADUR Pharma AG announces dosing of first healthy subjects in Phase 1 clinical trial of TOP-N53.
Read moreTOP-N53: A Clinical Drug Candidate for the Treatment of Non-healing Wounds.
Read more
